Form 4: USANA Health Sciences: Chief Sales Officer David Mulham Reports Stock Transactions

Chief Sales Officer David Mulham reports transactions involving USANA Health Sciences stock, including the vesting of restricted stock units.

Summary

• David Mulham, Chief Sales Officer of USANA Health Sciences, reported transactions involving the company's stock on February 8, 2025.
• These transactions involved the vesting of restricted stock units (RSUs) which convert into common stock.
• Specifically, 1,677 RSUs vested, converting into 1,677 shares of common stock, and 2,573 RSUs vested, converting into 2,573 shares of common stock.
• Following these transactions, Mulham directly owns 13,436 shares and 16,009 shares of common stock, respectively.
• He also directly owns 16,603 and 14,030 restricted stock units, respectively.
• The RSUs vest 25% annually on the anniversary of February 8th, 2021 and February 8th, 2024.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by an officer, with no inherently positive or negative implications.

Positives

• The vesting of restricted stock units indicates that Mulham is meeting the conditions of his compensation package.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine vesting of stock options.

Key Dates

Keywords

USANA Health Sciences, David Mulham, Chief Sales Officer, stock transactions, restricted stock units, Form 4, USNA